Cargando…
Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data
Hypertension is a heterogeneous disease for which role sharing in treatment between specialized facilities and small clinics is needed for efficient healthcare provision. However, the Japanese healthcare system has a “free access” attribute; therefore, nobody can control treatment resource allocatio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872892/ https://www.ncbi.nlm.nih.gov/pubmed/32934368 http://dx.doi.org/10.1038/s41440-020-00549-2 |
_version_ | 1783649278152933376 |
---|---|
author | Hiragi, Shusuke Sato, Noriaki Uchino, Eiichiro Kuroda, Tomohiro Yanagita, Motoko |
author_facet | Hiragi, Shusuke Sato, Noriaki Uchino, Eiichiro Kuroda, Tomohiro Yanagita, Motoko |
author_sort | Hiragi, Shusuke |
collection | PubMed |
description | Hypertension is a heterogeneous disease for which role sharing in treatment between specialized facilities and small clinics is needed for efficient healthcare provision. However, the Japanese healthcare system has a “free access” attribute; therefore, nobody can control treatment resource allocation. We aimed to describe the current situation of role sharing by comparing antihypertensive therapies among different types of medical facilities. We analyzed 1% sampled Japanese medical insurance claims data related to outpatient care as of October 2014. We divided the target patients into four groups according to the size of the facilities that issued the insurance claim for them. Among these groups, we compared the number of antihypertensive drugs and proportion of difficult-to-treat hypertensive cases and performed a stratified analysis. The proportion of patients with hypertension and diabetes mellitus receiving renin-angiotensin-aldosterone system inhibitors (RAASis) as the first-choice drug was also compared. We identified 3465, 1797, 2323, and 34,734 claims issued from large, medium-sized, small hospitals, and clinics, respectively. The mean number of hypertensive drugs was 1.96, 1.87, 1.81, and 1.69, respectively, and the proportion of difficult-to-treat hypertensive cases was 18.9, 17.0, 14.3, and 12.0%, respectively, with both showing significant differences. Stratified analysis showed similar results. The proportion of patients with hypertension and diabetes mellitus receiving RAASis as the first-choice drug was higher in large hospitals than in clinics. In conclusion, facility size is positively associated with the number of antihypertensive drugs and proportions of difficult-to-treat hypertensive cases. This finding describes the current role sharing situation of hypertension therapy in the Japanese healthcare system with a “free-access” attribute. |
format | Online Article Text |
id | pubmed-7872892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-78728922021-02-18 Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data Hiragi, Shusuke Sato, Noriaki Uchino, Eiichiro Kuroda, Tomohiro Yanagita, Motoko Hypertens Res Article Hypertension is a heterogeneous disease for which role sharing in treatment between specialized facilities and small clinics is needed for efficient healthcare provision. However, the Japanese healthcare system has a “free access” attribute; therefore, nobody can control treatment resource allocation. We aimed to describe the current situation of role sharing by comparing antihypertensive therapies among different types of medical facilities. We analyzed 1% sampled Japanese medical insurance claims data related to outpatient care as of October 2014. We divided the target patients into four groups according to the size of the facilities that issued the insurance claim for them. Among these groups, we compared the number of antihypertensive drugs and proportion of difficult-to-treat hypertensive cases and performed a stratified analysis. The proportion of patients with hypertension and diabetes mellitus receiving renin-angiotensin-aldosterone system inhibitors (RAASis) as the first-choice drug was also compared. We identified 3465, 1797, 2323, and 34,734 claims issued from large, medium-sized, small hospitals, and clinics, respectively. The mean number of hypertensive drugs was 1.96, 1.87, 1.81, and 1.69, respectively, and the proportion of difficult-to-treat hypertensive cases was 18.9, 17.0, 14.3, and 12.0%, respectively, with both showing significant differences. Stratified analysis showed similar results. The proportion of patients with hypertension and diabetes mellitus receiving RAASis as the first-choice drug was higher in large hospitals than in clinics. In conclusion, facility size is positively associated with the number of antihypertensive drugs and proportions of difficult-to-treat hypertensive cases. This finding describes the current role sharing situation of hypertension therapy in the Japanese healthcare system with a “free-access” attribute. Springer Singapore 2020-09-15 2021 /pmc/articles/PMC7872892/ /pubmed/32934368 http://dx.doi.org/10.1038/s41440-020-00549-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Hiragi, Shusuke Sato, Noriaki Uchino, Eiichiro Kuroda, Tomohiro Yanagita, Motoko Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data |
title | Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data |
title_full | Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data |
title_fullStr | Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data |
title_full_unstemmed | Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data |
title_short | Association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data |
title_sort | association between the size of healthcare facilities and the intensity of hypertension therapy: a cross-sectional comparison of prescription data from insurance claims data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872892/ https://www.ncbi.nlm.nih.gov/pubmed/32934368 http://dx.doi.org/10.1038/s41440-020-00549-2 |
work_keys_str_mv | AT hiragishusuke associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata AT satonoriaki associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata AT uchinoeiichiro associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata AT kurodatomohiro associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata AT yanagitamotoko associationbetweenthesizeofhealthcarefacilitiesandtheintensityofhypertensiontherapyacrosssectionalcomparisonofprescriptiondatafrominsuranceclaimsdata |